Treatment for pancreatic cancer: current therapy and continued progress
- PMID: 15887156
- DOI: 10.1053/j.gastro.2005.03.039
Treatment for pancreatic cancer: current therapy and continued progress
Abstract
In the last decade, continued efforts in pancreas cancer research have led to the development of new, more effective therapies. Additionally, progress in understanding the molecular processes underlying the development and progression of this disease provides hope for the development of more effective treatment strategies. Recent clinical trials have provided reason for hope that novel chemotherapy combinations and molecularly targeted agents will lead to improved clinical outcomes for patients with this disease. This article will summarize the data that has led to the current standards of therapy for patients with resectable and advanced pancreatic cancer and review new treatment strategies for this disease.
Similar articles
-
Updates and controversies in the treatment of pancreatic cancer.Clin Adv Hematol Oncol. 2006 Jan;4(1):47-54. Clin Adv Hematol Oncol. 2006. PMID: 16562370 Review.
-
Combinational therapy: new hope for pancreatic cancer?Cancer Lett. 2012 Apr 28;317(2):127-35. doi: 10.1016/j.canlet.2011.11.029. Epub 2011 Dec 2. Cancer Lett. 2012. PMID: 22138436 Review.
-
Chemotherapy for resectable and advanced pancreatic cancer.Oncology (Williston Park). 2001 Oct;15(10):1241-9, 1254; discussion 1254-64. Oncology (Williston Park). 2001. PMID: 11702956 Review.
-
The case for routine use of adjuvant therapy in pancreatic cancer.J Surg Oncol. 2007 Jun 1;95(7):597-603. doi: 10.1002/jso.20719. J Surg Oncol. 2007. PMID: 17230543 Review.
-
A review of systemic therapy for advanced pancreatic cancer.Clin Adv Hematol Oncol. 2003 Jul;1(7):430-4. Clin Adv Hematol Oncol. 2003. PMID: 16258429 Review.
Cited by
-
Clinical significance of clusterin expression in pancreatic adenocarcinoma.World J Surg Oncol. 2012 Jul 16;10:146. doi: 10.1186/1477-7819-10-146. World J Surg Oncol. 2012. PMID: 22799602 Free PMC article.
-
In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer.Pharm Res. 2010 Dec;27(12):2694-703. doi: 10.1007/s11095-010-0268-6. Epub 2010 Sep 25. Pharm Res. 2010. PMID: 20872054
-
Surgery for recurrent pancreatic ductal adenocarcinoma.Ann Surg. 2007 Apr;245(4):566-72. doi: 10.1097/01.sla.0000245845.06772.7d. Ann Surg. 2007. PMID: 17414605 Free PMC article.
-
Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.Gut. 2007 Sep;56(9):1266-74. doi: 10.1136/gut.2006.097188. Epub 2007 Apr 23. Gut. 2007. PMID: 17452424 Free PMC article.
-
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.Cancer Biol Ther. 2010 Nov 1;10(9):893-902. doi: 10.4161/cbt.10.9.13252. Epub 2010 Nov 1. Cancer Biol Ther. 2010. PMID: 20814245 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical